Inter Pharma Valuation
Is IP-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IP-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IP-R (THB3.6) is trading above our estimate of fair value (THB1.73)
Significantly Below Fair Value: IP-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IP-R?
Key metric: As IP-R is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is IP-R's PS Ratio? | |
|---|---|
| PS Ratio | 1.2x |
| Sales | ฿1.81b |
| Market Cap | ฿2.18b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.4x |
| Enterprise Value/EBITDA | 22.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does IP-R's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.7x | ||
KISS Rojukiss International | 2.6x | 8.4% | ฿2.8b |
TNR Thai Nippon Rubber Industry Public | 1.3x | n/a | ฿2.7b |
DDD Do Day Dream | 1.8x | n/a | ฿2.8b |
APCO Asian Phytoceuticals | 13.1x | n/a | ฿3.0b |
IP-R Inter Pharma | 1.2x | n/a | ฿2.2b |
Price-To-Sales vs Peers: IP-R is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (4.7x).
Price to Sales Ratio vs Industry
How does IP-R's PS Ratio compare vs other companies in the Asian Personal Products Industry?
| 12 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 12 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: IP-R is good value based on its Price-To-Sales Ratio (1.2x) compared to the Asian Personal Products industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is IP-R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.2x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate IP-R's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Do Day Dream
฿2.8b
Produces, researches and develops, markets, and distributes consumer goods in Thailand.
DDD
฿8.80
7D
0%
1Y
-9.7%
Jack Chia Industries (Thailand)
฿1.1b
Engages in the manufacture and distribution of pharmaceutical and cosmetic products in Thailand.
JCT
฿80.00
7D
-1.2%
1Y
0%
Jack Chia Industries (Thailand)
฿1.1b
Engages in the manufacture and distribution of pharmaceutical and cosmetic products in Thailand.
JCT-R
฿80.00
7D
-1.2%
1Y
0%